Drug Approval | November 12, 2021
Sun Pharma to introduce molnupiravir in India
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
The company has operations in North America, Asia, and Europe,
The drug helps in managing cholesterol
It is the world’s first DNA-based Covid vaccine
Subscribe To Our Newsletter & Stay Updated
